Ropivacaine
Ropivacaine. Long-acting amide local anesthetic — S-enantiomer of bupivacaine's racemate. Cardiotoxicity reduced vs bupivacaine (still… Subcutaneous half-life 1.9 h.
Long-acting amide local anesthetic — S-enantiomer of bupivacaine's racemate. Cardiotoxicity reduced vs bupivacaine (still real). Preferred for continuous epidural / peripheral nerve catheters where high cumulative doses occur.
EFFECT COMPARTMENT: CORRECTLY CITED, VERBATIM, AND MEASURED BETWEEN THE WRONG TWO COMPARTMENTS. The paper fits an equilibration delay between the AMOUNT REMAINING IN AN INJECTION DEPOT and the effect site, with a potency term expressed as a MASS rather than a concentration — that is perineural diffusion, not equilibration from the systemic circulation the solver actually feeds it. The number stays and is flagged, because deleting it would be worse. ROUTE: THE SAME MISMATCH ALREADY CORRECTED ON BUPIVACAINE, AND ROPIVACAINE HAS NO INTRAMUSCULAR PRODUCT AT ALL. Both routes were declared with everything hung on the intramuscular one, while the citation is explicitly an INTRAVENOUS infusion in six healthy men; the subcutaneous route was a dangling declaration with no dose and no parameters. Moved, exactly as the sibling was. TWO FINDINGS TRAVEL WITH IT. NO TRANSPLANT WITH BUPIVACAINE — I CHECKED THE COLLISION I PREDICTED: one paper reports both drugs in a single sentence and THIS RECORD CORRECTLY STORES ITS OWN NUMBER, not the neighbour. And the pharmacokinetic pair is a class-12 case whose own abstract names the mechanism — "the disposition of ropivacaine can be described by a BIEXPONENTIAL function" — with a steady-state volume against a terminal half-life implying a clearance about half the paper own figure. A MATRIX QUESTION IS FLAGGED DIRECTIONALLY AND NOT ACTED ON: both that volume and that clearance are BLOOD-referenced while the solver is plasma-referenced, which would narrow the gap rather than close it, and no verbatim blood-to-plasma ratio was found.
Pharmacokinetics
- Subcutaneous — t½ 1.9 h · F 100% · Vd 59 L
Sources: PMID:2589653